Discover 1,057 paid clinical trials in Provo, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,057
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
for
Atrial Fibrillation, Stroke, Bleeding
Location: Murray UT, Salt Lake City UT, Los Angeles CA,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04045665
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
for
Lichen Sclerosus
Location: Murray UT, Scottsdale AZ, Phoenix AZ, Fremont CA,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07335588
Phase 3, Recruiting
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
for
Migraine
Location: Salt Lake City UT, Las Vegas NV, Phoenix AZ,
Sponsor: Aspeya, Inc.
Sex: All
Age: 18 - 65
Code: NCT07646613
Phase 2, Recruiting
The Beat Pain Better Trial
for
Osteoarthritis, Chronic Pain Management
Location: Salt Lake City UT, West Valley City UT
Sponsor: University of Utah
Sex: All
Age: 45+
Code: NCT06932887
Phase 3, Recruiting
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
for
Acute Post Operative Pain, Third Molar Extraction Surgery
Location: Salt Lake City UT
Sponsor: Arcato Laboratories, Inc.
Sex: All
Age: 18 - 55
Code: NCT06864884
Early Phase 1, Recruiting
nCap Pain Relief Patch vs. Placebo
for
Osteoarthritis, Knee
Location: Salt Lake City UT
Sponsor: nCap Medical
Sex: All
Age: 40 - 70+
Code: NCT04753567
Recruiting
A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years
for
Pain
Location: Salt Lake City UT
Sponsor: HALEON
Sex: All
Age: 6 - 11
Code: NCT07632274
Phase 1, Recruiting
Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy
for
Hallux Valgus, Bunionectomy
Location: Millcreek UT
Sponsor: Rebel Medicine Inc
Sex: All
Age: 18+
Code: NCT07574385
Phase 2, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: South Salt Lake UT, Arvada CO, Surprise AZ, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
for
Metastatic Castration Resistant Prostate Cancer
Location: Murray UT, Fort Worth TX, Dallas TX, Houston TX,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07723248
Phase 3, Recruiting
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
for
Myopia
Location: Salt Lake City UT, Tucson AZ, Fullerton CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 5 - 11
Code: NCT07095894
Phase 3, Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Salt Lake City UT, Laramie WY, Boise ID, Glendale AZ,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase 3, Recruiting
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
for
Non-Exudative Age Related Macular Degeneration
Location: Murray UT
Sponsor: MacuCLEAR, Inc.
Sex: All
Age: 50 - 70+
Code: NCT02127463
Phase 2, Phase 3, Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration